Dr. Lal PathLabs Limited has officially finalized the acquisition of Shahbazkers Diagnostic Centre Private Limited (SDCPL) as of May 1, 2026. Having secured a 100% stake in the firm, this move officially integrates SDCPL into the company as a wholly owned subsidiary. The transaction follows the signing of a Share Purchase Agreement and marks a significant step in the company’s regional expansion strategy within the diagnostic services sector.
Strategic Expansion Finalized
Dr. Lal PathLabs Limited has successfully concluded the takeover of Shahbazkers Diagnostic Centre Private Limited (SDCPL). Following the initial disclosure on April 30, 2026, the company confirmed the final completion of the deal on May 1, 2026. The full acquisition of equity shares solidifies the company’s footprint in the diagnostic space.
Future Operational Structure
With the execution of the Share Purchase Agreement now complete, SDCPL will function as a wholly owned subsidiary of Dr. Lal PathLabs Limited. This integration is expected to bolster the company’s operational capacity and service network. By bringing SDCPL under its corporate umbrella, Dr. Lal PathLabs continues its commitment to scaling its healthcare delivery infrastructure and enhancing patient access to high-quality diagnostic services.
Source: BSE
